Shota Rustaveli National Science Foundation of Georgia disseminates information about the 14th grant call of Innovative Medicines Initiative (IMI).
The Innovative Medicines Initiative (IMI) is a partnership between the European Union and the European pharmaceutical industry. IMI facilitates open collaboration in research to advance the development of, and accelerate patient access to, personalized medicines for the health and wellbeing of all, especially in areas of unmet medical need.
Source: rustaveli.org.ge